What does MPM Bio IV NVS Strategic Fund invest in?
MPM Bio IV NVS Strategic Fund invests most often at Series C and Growth (75% of the rounds on record), in sectors such as Finance and Financial Services.
Last cheque observed Apr 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
4 rounds on record
Mostly Series C and Growth: 75% of its rounds
Sole investor in 1 rounds, median $10M
Every round we can evidence, newest first4 appearances
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as MPM Bio IV NVS Strategic Fund. A count of rooms they were both in, not a relationship either has claimed.
MPM Bio IV NVS Strategic Fund invests most often at Series C and Growth (75% of the rounds on record), in sectors such as Finance and Financial Services.
4 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2013.
The median round it joins is $29M.
No investments in the last 12 months; the latest was in Apr 2013.
Most often BB Biotech Ventures (2 rounds together) and MPM Capital (2 rounds together).
MPM Bio IV NVS Strategic Fund is a VC firm.
From 4 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it